COMMONWEALTH BIOTECHNOLOGIES, INC. DEF 14A

Company

Inhibitor Therapeutics, Inc.

Filed

March 15, 1999

Period of Report

April 15, 1999

Accession Number

0000916641-99-000181

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →